Droghini, H. R., Abonia, J. P., Collins, M. H., Milner, J. D., Lyons, J. J., Freeman, A. F., Mukkada, V. A., Risma, K. A., Rothenberg, M. E., & Schwartz, J. T. (2022). Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. The Journal of Allergy and Clinical Immunology: In Practice, 10(7), 1903–1906. https://doi.org/10.1016/j.jaip.2022.01.012